BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30651591)

  • 1. Transferrin receptor-involved HIF-1 signaling pathway in cervical cancer.
    Xu X; Liu T; Wu J; Wang Y; Hong Y; Zhou H
    Cancer Gene Ther; 2019 Nov; 26(11-12):356-365. PubMed ID: 30651591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preserved miR-361-3p Expression Is an Independent Prognostic Indicator of Favorable Survival in Cervical Cancer.
    Liu S; Song L; Yao H; Zhang L; Xu D; Li Q; Li Y
    Dis Markers; 2018; 2018():8949606. PubMed ID: 30344797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron metabolism protein transferrin receptor 1 involves in cervical cancer progression by affecting gene expression and alternative splicing in HeLa cells.
    Huang N; Wei Y; Cheng Y; Wang X; Wang Q; Chen D; Li W
    Genes Genomics; 2022 Jun; 44(6):637-650. PubMed ID: 35066810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data.
    Liu H; Liu L; Zhu H
    J Comput Biol; 2019 Apr; 26(4):387-395. PubMed ID: 30762435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients.
    Li X; Tian R; Gao H; Yang Y; Williams BRG; Gantier MP; McMillan NAJ; Xu D; Hu Y; Gao Y
    Sci Rep; 2017 Nov; 7(1):16495. PubMed ID: 29184082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients.
    Wang Q; Vattai A; Vilsmaier T; Kaltofen T; Steger A; Mayr D; Mahner S; Jeschke U; Hildegard Heidegger H
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA cTFRC acts as the sponge of MicroRNA-107 to promote bladder carcinoma progression.
    Su H; Tao T; Yang Z; Kang X; Zhang X; Kang D; Wu S; Li C
    Mol Cancer; 2019 Feb; 18(1):27. PubMed ID: 30782157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of long non-coding RNA expression profiles in lymph node metastasis of early-stage cervical cancer.
    Shang C; Zhu W; Liu T; Wang W; Huang G; Huang J; Zhao P; Zhao Y; Yao S
    Oncol Rep; 2016 Jun; 35(6):3185-97. PubMed ID: 27035672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics and survival analysis of glia maturation factor-γ in pan-cancers.
    Lan A; Ren C; Wang X; Tong G; Yang G
    BMC Cancer; 2021 Apr; 21(1):423. PubMed ID: 33863293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
    Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
    J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome sequencing profiles of cervical cancer tissues and SiHa cells.
    Chen T; Yang S; Xu J; Lu W; Xie X
    Funct Integr Genomics; 2020 Mar; 20(2):211-221. PubMed ID: 31456134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of HIF-1A and its implication in the hypoxia pathway in primary advanced uterine cervical carcinoma.
    Łuczak MW; Roszak A; Pawlik P; Kędzia H; Lianeri M; Jagodziński PP
    Oncol Rep; 2011 Nov; 26(5):1259-64. PubMed ID: 21887475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node metastasis in lung squamous cell carcinoma and identification of metastasis-related genes based on the Cancer Genome Atlas.
    Dong M; Gong H; Li T; Li X; Liu J; Zhang H; Liu M; Chen G; Liu H; Chen J
    Cancer Med; 2019 Oct; 8(14):6280-6294. PubMed ID: 31482686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of the role of matrix metalloproteinase-1 in cervical cancer.
    Tian R; Li X; Gao Y; Li Y; Yang P; Wang K
    Int J Oncol; 2018 Apr; 52(4):1198-1208. PubMed ID: 29436615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome profiling of the cancer and adjacent nontumor tissues from cervical squamous cell carcinoma patients by RNA sequencing.
    Peng G; Dan W; Jun W; Junjun Y; Tong R; Baoli Z; Yang X
    Tumour Biol; 2015 May; 36(5):3309-17. PubMed ID: 25586346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia inducible factor-1α-mediated activation of survivin in cervical cancer cells.
    Bai H; Ge S; Lu J; Qian G; Xu R
    J Obstet Gynaecol Res; 2013 Feb; 39(2):555-63. PubMed ID: 22925504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics analysis of gene expression profile data to screen key genes involved in intracranial aneurysms.
    Guo T; Hou D; Yu D
    Mol Med Rep; 2019 Nov; 20(5):4415-4424. PubMed ID: 31545495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.